Retatrutide Skincare Routine

    By Trimi Medical Team11 min read

    Rapid weight loss from retatrutide (up to 24.2% in Phase 2 trials per Jastreboff et al., NEJM 2023) places unique demands on skin. A targeted skincare routine focused on collagen support, hydration, and protection can help maintain skin quality during this transformation. This guide provides a practical, evidence-based routine for both face and body.

    Medical Disclaimer: This article is for informational purposes only. Retatrutide is an investigational drug not yet approved by the FDA. Consult a dermatologist for personalized skincare recommendations, especially before starting retinoids.

    Morning Facial Routine

    • Gentle cleanser: Avoid stripping cleansers. Use a hydrating, pH-balanced cleanser (like CeraVe Hydrating or La Roche-Posay Toleriane).
    • Vitamin C serum (10-20% L-ascorbic acid): Stimulates collagen synthesis and provides antioxidant protection against UV and pollution. Apply to clean, dry skin.
    • Hyaluronic acid serum: Draws moisture into skin for plumping effect. Apply to damp skin for best results.
    • Moisturizer with niacinamide: Niacinamide strengthens the skin barrier, reduces inflammation, and supports collagen. Look for 5% concentration.
    • Broad-spectrum SPF 30-50: Non-negotiable. UV damage is the primary accelerator of collagen breakdown. Reapply every 2 hours when outdoors.

    Evening Facial Routine

    • Double cleanse: Oil-based cleanser first (removes sunscreen and makeup), then water-based cleanser.
    • Retinoid: The gold standard for collagen stimulation. Start with 0.025% tretinoin or OTC retinol 2-3 times per week and build to nightly use. Expect mild peeling initially.
    • Peptide serum: Matrixyl or copper peptides support collagen and elastin production. Use on nights when not using retinoid if skin is sensitive.
    • Rich moisturizer or facial oil: Lock in hydration overnight. Squalane oil, ceramide-rich creams, or rosehip oil are excellent options.

    Body Skincare Routine

    • Gentle body wash: Avoid hot water and harsh soaps that strip natural oils. Lukewarm water with a hydrating body wash.
    • Body retinol lotion: Apply to areas prone to loose skin (abdomen, arms, thighs). Body-specific retinol products are formulated at appropriate concentrations for larger areas.
    • Rich body moisturizer: Apply immediately after showering to damp skin. Look for ingredients like shea butter, glycerin, hyaluronic acid, and ceramides.
    • Dry brushing (optional): Before showering, gentle dry brushing stimulates blood flow and may support lymphatic drainage. Use light pressure in upward strokes toward the heart.

    Key Ingredients Explained

    IngredientBenefitEvidence Level
    Retinoids (tretinoin/retinol)Collagen stimulation, cell turnoverStrong
    Vitamin C (L-ascorbic acid)Collagen synthesis, antioxidantStrong
    NiacinamideBarrier support, inflammation reductionStrong
    Hyaluronic acidHydration, plumpingModerate
    Peptides (Matrixyl)Collagen signalingModerate
    CeramidesBarrier repair, moisture retentionStrong

    Hydration From the Inside

    External skincare is only half the equation. Internal hydration is equally important: drink at least 64 oz of water daily (more if experiencing GI side effects), eat water-rich foods (cucumber, watermelon, berries), limit caffeine and alcohol (both are dehydrating), and consider collagen peptide supplementation (5-10g daily).

    What to Avoid

    • Excessive hot water (strips natural oils)
    • Harsh scrubs or over-exfoliation
    • Tanning beds and unprotected sun exposure
    • Smoking and excessive alcohol
    • Products with high fragrance content (can irritate and sensitize skin)

    GLP-1 Treatment With Complete Support

    Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with medical guidance that addresses all aspects of your weight loss journey. Learn how Trimi works.

    Frequently Asked Questions

    When should I start a skincare routine?

    Ideally before or at the same time as starting retatrutide. Prevention is more effective than trying to repair damage after significant weight loss has occurred.

    Do I need expensive products?

    No. Affordable brands like CeraVe, The Ordinary, and La Roche-Posay offer evidence-based formulations at accessible price points. The key is using the right active ingredients consistently, not brand prestige.

    Can I use retinol and vitamin C together?

    Best practice is to use vitamin C in the morning and retinol at night. While they can technically be used together, this combination may irritate sensitive skin. Alternating AM/PM avoids potential irritation.

    How long before I see results from skincare?

    Expect 8-12 weeks of consistent use before seeing meaningful improvements in skin texture and firmness. Sunscreen benefits are immediate (prevention), while collagen-building ingredients take time.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What does the published clinical evidence show for retatrutide?

    Peer-reviewed evidence: Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023). Trimi is preparing for launch; compounded availability depends on FDA-cleared compounding pathways. Results vary by individual; eligibility is determined by a licensed clinician.

    Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. — Jastreboff et al. Phase 2 trial, NEJM 2023
    Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg. — Rosenstock et al. Phase 2 T2D trial, Lancet 2023

    Key Takeaways

    • Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023)
    • Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg. (Source: Rosenstock et al. Phase 2 T2D trial, Lancet 2023)
    • Retatrutide is investigational and not FDA-approved as of publication. Trial findings reported here are from Phase 2 / Phase 3 studies in peer-reviewed sources cited below.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 27, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Kaplan LM, Frías JP, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2301972
    2. Rosenstock J, Frias J, Jastreboff AM, et al. (2023). Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial. The Lancet.Read StudyDOI: 10.1016/S0140-6736(23)01053-X
    3. ClinicalTrials.gov (2024). A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Are Overweight (TRIUMPH-1) — NCT05929066. ClinicalTrials.gov.Read Study
    4. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    5. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    6. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Retatrutide

    Retatrutide 2mg

    Retatrutide 4mg is the first therapeutic dose — where real weight loss begins. 17.5% average weight loss at this dose alone. Expected results, side effects, and when to consider escalating.

    Retatrutide vs phentermine: 24.2% weight loss with a triple-agonist hormone vs 5-10% with a stimulant. Mechanism, side effects, duration, and why the comparison isn

    Detailed comparison of retatrutide vs tirzepatide: 24.2% vs 22.5% weight loss, mechanism differences, side effects, cost projections, and whether to wait or start now.

    Retatrutide vs Contrave (naltrexone/bupropion): 24.2% weight loss vs 5-8%. How the triple agonist compares to the oral combination pill in efficacy, mechanism, side effects, and cost.

    Start your GLP-1 journey — from $99/mo

    Get Started